Needle and syringe programmes

Hepatitis B and C: ways to promote and offer testing to people at increased risk of infection. NICE public health guidance 43 (2012)

Drug misuse: opioid detoxification. NICE clinical guideline 52 (2007).

Drug misuse: psychosocial interventions. NICE clinical guideline 51 (2007).

Interventions to reduce substance misuse among vulnerable young people. NICE public health guidance 4 (2007).

Naltrexone for the management of opioid dependence. NICE technology appraisal guidance 115 (2007).

Methadone and buprenorphine for the management of opioid dependence. NICE technology appraisal guidance 114 (2007).

Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C. NICE technology appraisal guidance 106 (2006).

Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B. NICE technology appraisal guidance 96 (2006).

Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C. NICE technology appraisal guidance 75 (2004).